Interview with Manuel Fernando Loaiza Sotomayor, President, Bagó Brazil
28.07.2012
Related Interviews
LatAm / AbbVie VP Talks Access, Transformational Leadership & Long-Term Strategy
In a wide-ranging interview, AbbVie’s Flavio Devoto outlines some of the key access challenges and opportunities in the diverse Latin American pharma market, his approach to being a transformational leader…
Sarah Aiosa – SVP & President, MSD Latin America
Sarah Aiosa oversees the entire Latin America region for MSD, where the global giant is looking to build on its 100-year legacy by better addressing the continent’s health inequities and…
Henrique Tada – Executive Director, ALANAC, Brazil
Henrique Tada of ALANAC, the association that brings together Brazil’s domestic pharma companies, comments on the evolution of the Brazilian generics, biosimilars, and value-added medicines markets, local laboratories’ internationalisation efforts,…
Vietnam / Opportunities Abound in $6.5bn Pharma Market
As geopolitical tensions between China and the US increase and pharma industry stakeholders are increasingly looking elsewhere in Asia to diversify their supply chains, Vietnam has emerged as a highly…
Opinion / Health at the UN General Assembly: Innovation & Equity for Pandemic Preparedness
Ahead of the 78th session of the United Nations General Assembly (UNGA78), IFPMA Director General Thomas Cueni underscores the need for pandemic preparedness plans to support innovation and equity. Global…
Morocco / Recipharm’s Bet on Africa's Vaccine Independence
The COVID-19 pandemic exposed Africa’s dependence on overseas production as vaccines were quickly rolled out in other parts of the world while African countries remained at the bottom of the…
